Gene-to-Protein Production

From Sequence to Assay-Ready Protein. AI-Guided. Parallel-Screened. Quality-Validated.
AI-Guided Construct Design High-Throughput Expression Scalable Purification

Seed-stage biotechs lack protein infrastructure; pharma teams battling membrane proteins need native-conformation supply. We deliver AI-optimized constructs, parallel expression screening, and crystallization-grade purification — closing the gap between sequence and structure.

Why Gene-to-Protein Production Is the Critical Foundation

Structure-based drug design without reliable protein supply is synthesis without substrate. Seed-stage biotechs lack expression infrastructure; big-pharma teams need proven membrane-protein and nanodisc expertise. Our AI-Enhanced Structural Analysis platform integrates AlphaFold Protein Structure Prediction-guided construct design with parallel screening and scalable purification, delivering assay-ready proteins directly into AI-Assisted X-ray Crystallography Services, AI-Enhanced Cryo-EM Services, or Hit Biophysical Characterization workflows.

What Sets the Platform Apart

AI-Guided Construct Design

AlphaFold Protein Structure Prediction pLDDT maps guide truncation boundaries and solubility-tag selection, cutting trial-and-error by 30–50%.

Multi-System Parallel Screening

E. coli, yeast, insect, and mammalian cells screened in parallel; optimal expression conditions locked within 1 week.

Membrane Protein & Nanodisc Expertise

Specialized detergent screening, lipid reconstitution, and MSP nanodisc assembly preserve native membrane-protein conformations for Membrane Protein & Lipid MD Simulation.

Technology Suite

AI-Assisted Construct Engineering & Parallel Expression Screening

AI-optimized construct design and multi-host parallel screening for rapid expression condition identification.

Laboratory monitor displaying AlphaFold protein structure prediction with pLDDT confidence.

Key Features:

  • AlphaFold-Guided Truncation Mapping — pLDDT/pAE confidence scores from AlphaFold Protein Structure Prediction define soluble domain boundaries and flag disordered termini for removal, reducing expression failure rates.
  • Host-Optimized Codon Engineering — Deep-learning codon optimization tailored to each expression host (E. coli, Pichia, Sf9, HEK293) improves yield and solubility.
  • 96-Well Parallel Expression Screening — Four-host, multi-vector small-scale induction with SDS-PAGE solubility readout; 96 targets assessed in 1 week.
  • ML Tag Recommendation — Proprietary classifiers trained on 500+ in-house productions recommend fusion partners (MBP, GST, SUMO, Fc) for optimal folding.

Ideal For: Virtual biotechs without wet-lab infrastructure; difficult targets (kinases, GPCRs, ion channels); programs requiring rapid protein supply for Molecular Docking Services or Virtual Screening Services.

What We Offer: A fully outsourced gene-to-protein pipeline. You provide a sequence; we deliver expression reports, purified protein, and a validated COA. AI-guided design compresses traditional months-long construct optimization into weeks, while parallel screening ensures no expression host is overlooked.

Scalable Purification & Quality Validation

Automated chromatography scale-up with rigorous homogeneity, activity, and stability assessment.

ÄKTA pure chromatography system showing UV280 elution peaks on the monitor with fraction collector tubes in the foreground.

Key Features:

  • AKTA Pure Chromatography Scale-Up — Automated affinity capture (IMAC, Strep-Tactin) followed by IEX and SEC polishing; milligram to gram scale.
  • SEC-HPLC & DLS Profiling — Rigorous homogeneity and aggregation-state assessment before release.
  • Membrane Protein Reconstitution — Detergent exchange, liposome insertion, or MSP nanodisc assembly for native lipid-bilayer environments.
  • Activity & Thermal Validation — BLI/SPR binding confirmation and NanoDSF thermal stability profiling to predict crystallizability.

Ideal For: Crystal Grade Protein Preparation for AI-Assisted X-ray Crystallography Services; biophysical screening campaigns; antibody-antigen complex assembly for AI for Antibody & Biologics.

What We Offer: Every batch ships with a COA (concentration, purity, endotoxin, activity, thermal stability). Membrane proteins are delivered in nanodiscs or proteoliposomes with functional validation data, ready for MagHelix™ Co-crystallization and Soaking or Single Particle Analysis (SPA).

Platform Instrumentation

Core Instruments

Instrument Capability
Cytiva ÄKTA pure / ÄKTA avant Automated protein purification from analytical to preparative scale
Thermo Fisher Vanquish Neo UHPLC High-resolution SEC-HPLC for homogeneity and purity profiling
Formulatrix Rock Imager 1000 High-throughput crystallization screening and imaging
Malvern Zetasizer Nano DLS particle size and aggregation-state analysis
Sartorius Octet SF3 BLI activity and binding validation
NanoTemper Prometheus NT.48 NanoDSF thermal stability for crystallizability prediction
Thermo Fisher Krios G4 Downstream Cryo-EM structural validation
NVIDIA DGX A100 AlphaFold inference and protein-stability ML model training

Standardized Workflow

Project Workflow

A milestone-driven system from sequence to validated protein.

01 Target Review Week 1
02 AI-Guided Construct Design Week 1–2
03 Expression & Purification Week 2–4
04 Quality Validation Week 4
05 Downstream Handoff Week 4–6

01 Target Review

Deliverable: Construct proposal + MSA report

02 AI-Guided Construct Design

  • Gene synthesis and vector construction
  • Four-host small-scale expression screening
  • Solubility and yield assessment
Deliverable: Expression report + optimal condition summary

03 Expression & Purification

  • Scale-up culture and induction optimization
  • Affinity capture and polishing (IEX/SEC)
Deliverable: Purified protein + chromatograms

04 Quality Validation

  • SEC-HPLC purity check
  • DLS aggregation analysis
  • NanoDSF thermal stability
  • BLI activity validation
Deliverable: COA + quality report

05 Downstream Handoff

Deliverable: Downstream project starter pack

Sample Requirements

  • Target Sequence: Amino acid sequence (FASTA) or UniProt ID; membrane proteins require topology annotation
  • Expression System Preference: E. coli, yeast, insect, or mammalian (if known)
  • Post-Translational Modifications: Glycosylation, phosphorylation, or disulfide-bond requirements
  • Purity & Quantity: Screening grade (>90%) or crystallography grade (>95%); mg to g scale
  • Downstream Application: AI-Assisted X-ray Crystallography Services, AI-Enhanced Cryo-EM Services, SPR/BLI, or Molecular Docking Services

Standard Deliverables

  • Purified protein with COA (concentration, purity, endotoxin, activity, thermal stability)
  • Expression and purification technical report with chromatograms and gel images
  • AI-assisted construct design rationale and AlphaFold Protein Structure Prediction analysis summary
  • Stability assessment data (NanoDSF, DLS aggregation profiles)
  • Electronic data package (sequences, plasmid maps, raw analytical data)

Frequently Asked Questions

Case Study

Case #1: Isolation and Purification of Native R1 Complex

Goal: Isolate and purify the native R1 protein complex (four subunits: A, B, C, D) from tissue samples for downstream structural and functional studies.

Key Data:

  • Source: Mouse tissue samples (kidney, liver, skin, spleen)
  • Detection: Western blot identified B subunit (130 kDa) specifically in spleen RIPA lysate
  • Purification: Anti-B antibody-conjugated NHS-activated agarose affinity chromatography
  • Validation: SDS-PAGE and Western blot confirmed intact R1 complex purification with high specificity

Why it matters: Multi-subunit native complexes often resist recombinant expression. This case demonstrates our expertise in antibody-conjugated affinity chromatography for endogenous complex isolation — a critical capability when recombinant systems fail. For biotechs targeting native assemblies without expression clones, this provides a viable path to pure material. For pharma, the customized conjugation and purification workflow delivers structurally stable complexes for Cryo-EM or biophysical assay validation.

Western blot showing tissue-specific detection of R1 complex B subunit at 130 kDa in spleen RIPA sample.

Figure 1. Western blot analysis of mouse B protein across tissue samples. Red arrow indicates target band (130 kDa) in spleen RIPA lysate (Lane 11).

SDS-PAGE validation of antibody bead conjugation efficiency for affinity chromatography.

Figure 2. SDS-PAGE confirming anti-B antibody conjugation to NHS-activated agarose beads. Lane 1: pre-conjugation; Lane 2: post-conjugation.

Purified R1 complex analysis showing specific elution from anti-B antibody affinity resin.

Figure 3. SDS-PAGE (left) and Western blot (right) of purified R1 complex. FT: flow-through; W1-W2: washes; E1-E3: elutions. Red arrow indicates target protein.

Ready to Start Production?
From sequence to assay-ready protein — without building a protein lab.
Request Project Scoping →

Our technical team responds within 24 hours. All inquiries protected under NDA.